(Q54180136)

25 May 2018

title

Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure. (English)

1 reference

25 May 2018

main subject

heart failure

0 references

chronic heart failure

1 reference

S Adamopoulos

1

1 reference

25 May 2018

M Piepoli

2

1 reference

25 May 2018

F Qiang

3

1 reference

25 May 2018

E Pissimissis

4

1 reference

25 May 2018

M Davies

5

1 reference

25 May 2018

L Bernardi

6

1 reference

25 May 2018

C Forfar

7

1 reference

25 May 2018

P Sleight

8

1 reference

25 May 2018

A Coats

9

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 February 1995

1 reference

25 May 2018

published in

The Lancet

1 reference

25 May 2018

volume

345

1 reference

25 May 2018

issue

8946

1 reference

25 May 2018

page(s)

344-349

1 reference

25 May 2018

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Drug-induced conditioning in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Density and functioning of human lymphocytic beta-adrenergic receptors during prolonged physical exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Beta-adrenoceptor adaptation to acute exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Effects of physical training in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Validation of the beat to beat measurement of blood velocity in the human ascending aorta by a new high temporal resolution Doppler ultrasound spectral analyser

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Determination of norepinephrine apparent release rate and clearance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Defective cardiac parasympathetic control in patients with heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist Pirbuterol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990339-9

7 January 2021

10.1016/S0140-6736(95)90339-9

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018